Prenatal opioid use is associated with increased maternal and infant mortality, prematurity, and poor neonatal outcomes.
It is essential that clinicians, as well as those working in dispensaries, must educate women about the risks associated with cannabis use during pregnancy. Â
Several recent studies have examined patterns of opioid use in women receiving opioid prescriptions for pain management after delivery. Â
Parenting support, maternal bonding with the infant, engagement in an OUD treatment program, and recovery-specific support systems promoted recovery in postpartum women with opioid use disorders.
Screening, Brief Intervention and Referral to Treatment or SBIRT has been shown to be a quick and effective means of identifying and intervening with patients whose patterns of use put them at risk for, or who already have, substance-related health problems.
Heavy cannabis use during pregnancy was associated with increased risk for small for gestational age, preterm birth, low birth weight, and death during the first year of life.
This study demonstrates higher rates of treatment continuation in postpartum women with opioid use disorders if medication treatment (methadone or buprenorphine) is initiated early and maintained throughout pregnancy.
A significant number of women consume cannabis while breastfeeding. What do we know about the effects of cannabis on the nursing infant?
We continue to see more and more women of reproductive age using marijuana in various forms. While marijuana is viewed by some as a safe alternative for the treatment of various maladies associated with pregnancy, [...]
While the use of alcohol and tobacco during pregnancy is falling, the use of cannabis and opioids is increasing. The American College of Obstetricians and Gynecologists now recommends universal screening for substance use to be [...]
